
USA - NASDAQ:ESRX - US30219G1085
The current stock price of ESRX is 92.33 null. In the past month the price decreased by -3.11%. In the past year, price increased by 23.88%.
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
EXPRESS SCRIPTS HLDG CO
ONE EXPRESS WAY
SAINT LOUIS MO 63121
CEO: Timothy Wentworth
Phone: 314-996-0900
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
The current stock price of ESRX is 92.33 null. The price decreased by -3.62% in the last trading session.
ESRX does not pay a dividend.
ESRX has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
ESRX stock is listed on the Nasdaq exchange.
EXPRESS SCRIPTS HLDG CO (ESRX) has a market capitalization of 52.06B null. This makes ESRX a Large Cap stock.
ChartMill assigns a technical rating of 3 / 10 to ESRX. When comparing the yearly performance of all stocks, ESRX is one of the better performing stocks in the market, outperforming 93.2% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to ESRX. While ESRX belongs to the best of the industry regarding profitability, there are concerns on its financial health.
Over the last trailing twelve months ESRX reported a non-GAAP Earnings per Share(EPS) of 8.58. The EPS increased by 25.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.83% | ||
| ROA | 8.84% | ||
| ROE | 23.82% | ||
| Debt/Equity | 0.63 |